Literature DB >> 199614

Use of sodium polyanetholesulfonate-CaCl2 for removal of serum nonspecific inhibitors of rubella hemagglutination: comparison with other polyanion-divalent cation combinations.

M L Ellins, J B Campbell.   

Abstract

By using trypsin-treated human type O cells as indicators, we compared the abilities of four polyanion-divalent cation combinations (heparin-MnCl(2); high-and low-molecular-weight dextran sulfate-CaCl(2); and sodium polyanetholesulfonate [SPS]-CaCl(2)) for removal of serum non-immunoglobulin (lipoprotein) inhibitors of rubella hemagglutination. The combination of SPS-CaCl(2) was found to be the most effective, precipitating completely the pre-beta and beta-lipoproteins and reducing the alpha-lipoprotein levels by more than 50%. Hemagglutination patterns after this treatment were clear and stable, and, when normal sera were tested, hemagglutination-inhibition (HI) titers were comparable to those obtained after standard heparin-MnCl(2) treatment. High-molecular-weight dextran sulfate-CaCl(2) removed serum lipoproteins almost as effectively as SPS-CaCl(2). However, problems of nonspecific agglutination and the heavy hemagglutination patterns resulting made this combination unacceptable for routine purposes. Neither low-molecular-weight dextran sulfate-CaCl(2) nor heparin-MnCl(2) removed the pre-beta lipoproteins completely, and occasionally traces of beta-lipoprotein also remained after treatment. The presence of pre-beta lipoproteins in normal sera after treatment may be of no consequence in the HI test since we have found that the very-low-density lipoprotein fractions obtained by ultracentrifugal methods from normal sera (those corresponding to the pre-beta fractions obtained by electrophoresis) had no HI activity. However, very-low-density lipoprotein fractions from all hyperlipemic sera tested had HI activity (titers ranging from 1:16 to 1:1,024) which, in the majority of cases, was not eliminated after heparin-MnCl(2) treatment. In every case, treatment with SPS-CaCl(2) removed this nonspecific activity completely. Since hyperlipemic sera may occasionally be encountered in routine rubella HI antibody testing, we recommend the use of SPS-CaCl(2) rather than heparin-MnCl(2) for pretreatment of sera.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 199614      PMCID: PMC274773          DOI: 10.1128/jcm.6.4.348-358.1977

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--III. Inhibition of C4 and C2 binding site(s) on C1s by polyanions.

Authors:  M Loos; J E Volanakis; R M Stroud
Journal:  Immunochemistry       Date:  1976-09

2.  An inhibitor to rubella hemagglutination present in bovine albumin preparations: its removal by treatment with kaolin.

Authors:  J B Campbell; M L Ellins; C Tasios
Journal:  Med Microbiol Immunol       Date:  1977-07-18       Impact factor: 3.402

3.  Lipid abnormalities and acute pancreatitis.

Authors:  J L Cameron
Journal:  Hosp Pract       Date:  1977-04

4.  Human serum lipoproteins as inhibitors of haemagglutination for selected togaviruses.

Authors:  K F Shortridge; W K Ho
Journal:  J Gen Virol       Date:  1974-04       Impact factor: 3.891

Review 5.  Practical methods for plasma lipoprotein analysis.

Authors:  F T Hatch
Journal:  Adv Lipid Res       Date:  1968

6.  Rubella hemagglutination-inhibition test: false-positive reactions in sera contaminated with bacteria.

Authors:  J B Campbell; M Romach; M L Ellins
Journal:  J Clin Microbiol       Date:  1976-11       Impact factor: 5.948

7.  Inactivation of classical and alternative pathway-activated bactericidal activity of human serum by sodium polyanetholsulfonate.

Authors:  W H Traub; I Kleber
Journal:  J Clin Microbiol       Date:  1977-03       Impact factor: 5.948

8.  Use of trypsin-modified human erythrocytes in rubella hemagglutination-inhibition testing.

Authors:  E P Quirin; D B Nelson; S L Inhorn
Journal:  Appl Microbiol       Date:  1972-09

9.  Serum lipoproteins as inhibitors of haemafflutination by rubella virus.

Authors:  W K Ho
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

10.  Comparison of the activities in inhibition of haemagglutination by different togaviruses for human serum lipoproteins and their constituents.

Authors:  K F Shortridge; W K Ho
Journal:  J Gen Virol       Date:  1976-12       Impact factor: 3.891

View more
  1 in total

1.  Nonspecific reactions in the hemagglutination inhibition test for detection of rubella antibodies.

Authors:  D B Budzko; D F Jelinek; B W Wilcke
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.